Trinity Biotech and University at Buffalo Partner to Commercialize Sjögren’s Syndrome Biomarkers
The collaboration focuses on advancing proprietary biomarkers for the earlier and more accurate detection of the autoimmune disease.
Read More
Search Results for: lung cancer
New Billing Code Approved for Spinal Fluid Tumor Cell Test
The AMA has approved a new PLA CPT code, effective July 1, 2026, to support claims processing and clinical adoption in CNS metastases diagnostics.
Read More
Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform
20/20 BioLabs’ AI-powered multi-cancer early detection test, OneTest for Cancer, is now available to approximately 40,000 clinicians via the Evexia Diagnostics platform.
Read More
New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
Read More
EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
Read More